Centerline Biomedical, Inc., a Cleveland Clinic spinout company, raised $10m in financing.
The company intends to use the funds to enhance its team and commercialize its solution.
Led by Philip D. Rackliffe, CEO, and Vikash Goel, CTO, Centerline Biomedical is also announcing updates regarding its IOPS™ platform technology designed to improve patient and caregiver safety, reduce procedure time, limit harmful radiation and contrast dye, and overall reduce costs to healthcare systems while improving access to care. Limited launch commercialization is beginning in the second quarter of 2020, with full launch beginning in the second half of the year. Centerline is hiring key talent across the organization including Head of R&D Sreenivasan “Sreeni” Narayanan, and Head of Operations Sonya Snyder.